WASHINGTON, DC — A viral incident inside the Oval Office on Thursday captured a shocking moment when Gordon Findlay, a Novo Nordisk executive, suddenly collapsed during an official White House press conference. The footage quickly spread online, raising questions about Health and Human Services Secretary Robert F. Kennedy Jr.’s reaction as the event took an unexpected turn.
The gathering, led by President Donald Trump, was organized to announce a groundbreaking deal between the government and major pharmaceutical firms Eli Lilly and Novo Nordisk aimed at reducing the cost of obesity medications for millions of Americans. What began as a policy-driven presentation turned into a scene filled with tension and concern.
Video shows Gordon Findlay, Novo Nordisk Global Brand Director, losing his balance and collapsing beside the Resolute Desk while President Trump spoke.
Mehmet Oz, Administrator of the Centers for Medicare & Medicaid Services, quickly stepped forward to assist Findlay, preventing serious consequences. In the aftermath, journalists were escorted from the room as medical personnel responded to the emergency.
The incident sparked immediate online debate, with many users sharing clips questioning the reactions of attendees inside the Oval Office. Despite widespread speculation, officials later confirmed that Findlay was stable and received prompt medical care following the collapse.
Findlay’s presence at the White House related to ongoing discussions about collaboration between the administration and pharmaceutical leaders in improving access to weight-loss treatments. The episode briefly diverted attention from the policy announcement and stirred fresh discussion about public appearances of high-profile officials.
Author’s Summary: A medical emergency during President Trump’s Oval Office event involving a pharmaceutical executive sparked public speculation and briefly overshadowed a major health policy announcement.